UCSF

ZINC36294079

Substance Information

In ZINC since Heavy atoms Benign functionality
October 25th, 2009 16 Yes

Other Names:

(+)-ketamine; (2R)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone; (R)-(+)-ketamine

(+-)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride; (+-)-ketamine hydrochloride; 2-(o-chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride; ketamine HCl

(+-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride; (+-)-Ketamine hydrochloride; C13H16ClNO.HCl; CI 581; CL 369; CN-52,372-2; Calipsol; Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, hydrochloride; Cyclohexanone, 2-(2-chlorophenyl)-2-

(+-)-Ketamine

(+-)-Ketamine; 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone; 2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone; 2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone; BRN 2216965; C13H16ClNO; CI 581 base; CI-581; CLSTA 20; Calipsol; Calypsol; Cetamina [INN-Sp

(+-)-ketamine; 2-(methylamino)-2-(2-chlorophenyl)cyclohexanone; 2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone; DL-ketamine; Ketamine; NMDA; dl-ketamine; special K

(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone

(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone

(+/-)-Ketamine

(-)-Ketamine

(-)-Ketamine;(S)-(-)-Ketamine;(S)-Ketamine;CI 581 base;Ketamine Base;Ketamine HCL;L-Ketamine

(R)-ketamine

(S)-(-)-Ketamine

(S)-Ketamine

(±)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride

100477-72-3

1867-66-9; C07843; Ketamine hydrochloride

1867-66-9; D00711; Ketalar (TN); Ketamine hydrochloride (JP16/USP)

2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one

2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone

2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride

2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone

2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone

2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone

33643-45-7

33643-46-8; D07283; Esketamine (INN)

6740-88-1

6740-88-1; C07525; Ketamine

6740-88-1; D08098; Ketamine (INN); Tekam (TN)

79499-51-7

AC1L1GSH

AC1Q40UR

AKOS001053247

Anaket-V

BRN 2216965

C07525

C13H16ClNO

Calypsol

Cetamina

Cetamina [INN-Spanish]

CHEBI:138629; CHEBI:6122

CHEBI:138833

CHEBI:6121

CHEMBL742

CI 581 base

CI-581

CI-581; CL-369; CN-52372-2

CID3821

CL-369

CLSTA 20

CN-52372-2

cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-

Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI)

Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)-

Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI)

Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+/-)-

Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (.+-.)-

Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (.+/-.)-

Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-

Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+-)-

Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI)

Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (.+-.)-

D08098

DAP001148

DB01221

DEA No. 7285

DivK1c_000217

dl-Ketamine

EINECS 229-804-1

Esketamine

FDA)

Green

IDI1_000217

INN); Ketamine HCl (FDA

INN); Ketamine HCl (JAN

INN); Ketamine Hydrochloride (FDA

JAN

KBio1_000217

Ketaject

Ketaject; Ketalar; Ketanest

Ketalar

Ketalar base

ketamina; ketamine; ketaminum

Ketamine

Ketamine (BAN

Ketamine (INN)

Ketamine Base

Ketamine HCL

Ketamine Hydrochloride

Ketamine [INN:BAN]

Ketaminum

Ketaminum [INN-Latin]

Ketanest

Ketavet

Ketoject

Ketolar

l-Ketamine

LS-57301

MFCD00051420

MLS001331674

MolPort-001-838-070

NCGC00159480-02

NCGC00159480-03

NINDS_000217

NSC 70151

NSC70151

SMR000238141

Special K

T385

Tekam

Tekam (TN)

UNII-690G0D6V8H

USAN

USP

USP)

Vetalar

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 2.96 5.44 -6.15 1 2 0 29 237.73 2

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 4.64e-02 g/l DrugBank-approved
UniProt Database Links AK1CD_MESAU; ANS1B_HUMAN; ANS1B_RAT; ARC_CHICK; ARC_RAT; CD47_RAT; CELF2_HUMAN; CELF2_MOUSE; CELF2_PONAB; CELF2_RAT; CGA_CONDI; CKBR_CONSL; CKE_CONER; CKG_CONGE; CKL_CONLY; CKP1_CONPI; CKP2_CONPI; CKP3_CONPI; CKP_CONPU; CKR1A_CONRO; CKR1B_CONRO; CKR1C_CON ChEBI
PUBCHEM_PATENT_ID EP0008227A1; EP0015658A1; EP0081923A2; EP0093380A2; EP0105361A1; EP0116967A1; EP0125469A1; EP0128706A2; EP0128831A2; EP0128831B1; EP0132983A1; EP0132983B2; EP0133673A1; EP0142074A2; EP0142074B2; EP0152862A2; EP0156175A1; EP0160169A1; EP0161063A1; EP016106 IBM Patent Data

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
NMD3A-2-E Glutamate [NMDA] Receptor Subunit 3A (cluster #2 Of 6), Eukaryotic Eukaryotes 420 0.56 Binding ≤ 10μM
NMD3B-2-E Glutamate [NMDA] Receptor Subunit 3B (cluster #2 Of 6), Eukaryotic Eukaryotes 420 0.56 Binding ≤ 10μM
NMDE1-2-E Glutamate [NMDA] Receptor Subunit Epsilon 1 (cluster #2 Of 5), Eukaryotic Eukaryotes 420 0.56 Binding ≤ 10μM
NMDE2-1-E Glutamate [NMDA] Receptor Subunit Epsilon 2 (cluster #1 Of 5), Eukaryotic Eukaryotes 420 0.56 Binding ≤ 10μM
NMDE3-1-E Glutamate [NMDA] Receptor Subunit Epsilon 3 (cluster #1 Of 4), Eukaryotic Eukaryotes 420 0.56 Binding ≤ 10μM
NMDE4-2-E Glutamate [NMDA] Receptor Subunit Epsilon 4 (cluster #2 Of 6), Eukaryotic Eukaryotes 420 0.56 Binding ≤ 10μM
NMDZ1-2-E Glutamate (NMDA) Receptor Subunit Zeta 1 (cluster #2 Of 6), Eukaryotic Eukaryotes 420 0.56 Binding ≤ 10μM
Z104297-3-O Glutamate NMDA Receptor; GRIN1/GRIN2B (cluster #3 Of 3), Other Other 3200 0.48 Binding ≤ 10μM
Z104298-2-O Glutamate NMDA Receptor; GRIN1/GRIN2A (cluster #2 Of 2), Other Other 6100 0.46 Binding ≤ 10μM
Z104302-3-O Glutamate NMDA Receptor (cluster #3 Of 7), Other Other 860 0.53 Binding ≤ 10μM
Z104302-1-O Glutamate NMDA Receptor (cluster #1 Of 3), Other Other 8860 0.44 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
NMDZ1_HUMAN Q05586 Glutamate (NMDA) Receptor Subunit Zeta 1, Human 420 0.56 Binding ≤ 1μM
Z104302 Z104302 Glutamate NMDA Receptor 610 0.54 Binding ≤ 1μM
NMD3A_HUMAN Q8TCU5 Glutamate [NMDA] Receptor Subunit 3A, Human 420 0.56 Binding ≤ 1μM
NMD3B_HUMAN O60391 Glutamate [NMDA] Receptor Subunit 3B, Human 420 0.56 Binding ≤ 1μM
NMDE1_HUMAN Q12879 Glutamate [NMDA] Receptor Subunit Epsilon 1, Human 420 0.56 Binding ≤ 1μM
NMDE2_HUMAN Q13224 Glutamate [NMDA] Receptor Subunit Epsilon 2, Human 420 0.56 Binding ≤ 1μM
NMDE3_HUMAN Q14957 Glutamate [NMDA] Receptor Subunit Epsilon 3, Human 420 0.56 Binding ≤ 1μM
NMDE4_HUMAN O15399 Glutamate [NMDA] Receptor Subunit Epsilon 4, Human 420 0.56 Binding ≤ 1μM
NMDZ1_HUMAN Q05586 Glutamate (NMDA) Receptor Subunit Zeta 1, Human 420 0.56 Binding ≤ 10μM
Z104302 Z104302 Glutamate NMDA Receptor 610 0.54 Binding ≤ 10μM
Z104298 Z104298 Glutamate NMDA Receptor; GRIN1/GRIN2A 6100 0.46 Binding ≤ 10μM
Z104297 Z104297 Glutamate NMDA Receptor; GRIN1/GRIN2B 3200 0.48 Binding ≤ 10μM
NMD3A_HUMAN Q8TCU5 Glutamate [NMDA] Receptor Subunit 3A, Human 420 0.56 Binding ≤ 10μM
NMD3B_HUMAN O60391 Glutamate [NMDA] Receptor Subunit 3B, Human 420 0.56 Binding ≤ 10μM
NMDE1_HUMAN Q12879 Glutamate [NMDA] Receptor Subunit Epsilon 1, Human 420 0.56 Binding ≤ 10μM
NMDE2_HUMAN Q13224 Glutamate [NMDA] Receptor Subunit Epsilon 2, Human 420 0.56 Binding ≤ 10μM
NMDE3_HUMAN Q14957 Glutamate [NMDA] Receptor Subunit Epsilon 3, Human 420 0.56 Binding ≤ 10μM
NMDE4_HUMAN O15399 Glutamate [NMDA] Receptor Subunit Epsilon 4, Human 420 0.56 Binding ≤ 10μM
Z104302 Z104302 Glutamate NMDA Receptor 8860 0.44 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
CREB phosphorylation through the activation of CaMKII
EPHB-mediated forward signaling
Ras activation uopn Ca2+ infux through NMDA receptor
Unblocking of NMDA receptor, glutamate binding and activation

Analogs ( Draw Identity 99% 90% 80% 70% )